Suzhou Zelgen Biopharmaceuticals Co., Ltd.

SSE:688266.SS

114.92 (CNY) • At close June 6, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Omzet 167.642148.837143.42132.124108.009104.02762.177111.818108.11104.41292.49361.67543.72591.78256.16942.410-0.31727.9780000000
Kosten van de omzet 19.4689.9679.52822.3577.14920.7454.969.0037.4869.4168.3065.0553.3852.5081.712.0511.5350.0150.0120.06600.17600.24500.083
Brutowinst 148.174138.87133.892109.767100.85983.28257.217102.815100.62494.99684.18756.6240.34189.27454.45940.36-11.535-0.33327.966-0.0660-0.1760-0.2450-0.083
Brutowinstmarge 0.8840.9330.9340.8310.9340.8010.920.9190.9310.910.910.9180.9230.9730.970.95201.04810000000
Onderzoek- en ontwikkelingskosten 102.237115.21291.63289.16984.347152.467114.871128.42791.892105.241137.108134.104121.273172.312139.571113.64883.86392.17492.68268.82360.5269.19846.61341.85233.85848.75
Algemene en administratieve kosten 15.074-18.39430.585-3.60814.059-39.80931.867-31.80821.649-10.33337.6083.42523.190.8633.5015.17912.0661.5414.5916.33614.715-1.2114.01989.364139.998305.95
Verkoop- en marketingkosten 94.064-55.842135.07660.08460.1178.29554.54862.17955.46672.48164.41353.43637.35546.6949.29432.12811.63114.8747.8798.2024.1144.0282.3071.49500
Verkoop-, algemene en administratieve kosten 109.138-74.236166.05570.56174.74169.44286.41530.37177.11562.147102.02156.86160.54547.5582.79437.30723.69716.41522.4714.53818.8292.81816.32590.86139.998305.95
Overige kosten -33.184140.39-90.683-0.0580-0.402-0.319-0.109-6.1328.009-27.9685.961-5.335-1.438-4.7310.0630.002-0.004-00.638-1.7320.001-3.106-0.474-0.629-2.561
Bedrijfskosten 178.191181.365167.004159.73159.088221.909163.968167.985162.878195.397211.161196.927176.483240.278188.996155.512101.938115.427111.5883.99974.66370.29359.833136.342173.8352.139
Bedrijfsresultaat -30.017-42.495-33.112-49.963-58.228-138.627-94.207-61.794-60.367-97.226-126.974-140.307-136.142-152.864-118.772-103.452-83.957-101.102-66.704-70.543-66.479-69.622-60.863-135.644-173.66-351.013
Bedrijfsresultaat ratio -0.179-0.286-0.231-0.378-0.539-1.333-1.515-0.553-0.558-0.931-1.373-2.275-3.114-1.666-2.115-2.4390318.505-2.3840000000
Totaal overige inkomsten en kosten netto -0.30.050.00316.09312.60556.81-0.319-0.109-0.472-0.782-0.469-0.7118.539-1.438-4.66-0.0070.002-0.004-0-000.0010-000
Inkomen voor belasting -30.317-42.445-33.109-33.87-45.624-81.817-94.525-61.903-60.839-98.008-125.288-137.055-127.603-154.302-123.433-103.459-83.954-101.106-66.704-70.543-66.479-69.621-60.863-135.644-173.66-351.013
Inkomen voor belasting ratio -0.181-0.285-0.231-0.256-0.422-0.786-1.52-0.554-0.563-0.939-1.355-2.222-2.918-1.681-2.198-2.440318.519-2.3840000000
Belastingkosten -1.004-1.793-0.99-0.973-0.993-0.978-1.032-0.976-0.9630.614-0.932-0.833-0.854-0.482-0.901-0.95-0.823-5.82613.772-1.01-1.094-4.556-0.93114.698-1.016-3.387
Nettowinst -28.262-39.928-31.367-27.037-39.499-76.493-87.861-57.001-59.876-98.622-124.356-136.222-126.749-158.326-115.703-97.257-79.713-90.857-99.757-66.352-62.263-63.486-57.243-171.016-170.133-348.444
Nettowinstmarge -0.169-0.268-0.219-0.205-0.366-0.735-1.413-0.51-0.554-0.945-1.344-2.209-2.899-1.725-2.06-2.2930286.23-3.5660000000
WPA (Winst Per Aandeel) -0.11-0.153-0.12-0.1-0.15-0.29-0.34-0.22-0.25-0.41-0.52-0.57-0.53-0.66-0.48-0.41-0.33-0.39-0.23-0.3-0.28-0.36-0.32-0.95-0.95-1.95
Verwaterde WPA -0.11-0.153-0.12-0.1-0.15-0.29-0.34-0.22-0.25-0.41-0.52-0.57-0.53-0.66-0.48-0.4-0.33-0.39-0.23-0.3-0.28-0.35-0.32-0.95-0.95-1.95
EBITDA -23.111-35.347-26.661-11.554-40.521-124.199-74.095-40.803-40.083-72.63-101.169-120.003-111.316-137.628-106.869-91.042-71.798-92.109-57.97-61.541-65.661-53.38-58.772-124.414-168.29-343.121
EBITDA ratio -0.138-0.237-0.186-0.087-0.375-1.194-1.192-0.365-0.371-0.696-1.094-1.946-2.546-1.5-1.903-2.1470290.175-2.0720000000